October 2003 Volume 5, Issue 8:
Early studies indicate targeted radioactive drug may expand treatment options for myeloma
By Gregory Wiseman, M.D.
Angela Dispenzieri, M.D.
The studies involve the drug Quadramet, one of a new class of drugs that target radiation directly to bone and spare the rest of the body from exposure.
|
step 1: get the correct diagnosis
publications
back
print
related articles
Be the first to comment